Terug
Dagbereik
€ 32,48
€ 33,76
52-Weeksbereik
€ 18,92
€ 43,15
Volume
1.905.132
50D / 200D Gem.
€ 32,02
/
€ 31,99
Vorige Slotkoers
€ 32,17
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,7 | 0,2 |
| P/B | 6,0 | 3,0 |
| ROE % | -47,3 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 103,00
+210.2%
Low: € 99,00
High: € 107,00
Forward WPA
-€ 4,23
Omzet Sch.
7,17M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,66
€ 2,66 – € 2,66
|
1,30B | 5 |
| FY2029 |
-€ 1,80
-€ 1,80 – -€ 1,80
|
450,85M | 10 |
| FY2028 |
-€ 4,16
-€ 8,20 – -€ 0,03
|
154,11M | 12 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-11 | -€ 0,89 | -€ 1,38 | -55,0% |
| 2025-10-22 | -€ 0,70 | -€ 0,81 | -15,7% |
| 2025-07-23 | -€ 0,44 | -€ 0,58 | -31,8% |
| 2025-04-23 | -€ 0,34 | -€ 0,41 | -20,6% |
| 2025-02-05 | -€ 0,28 | -€ 0,32 | -14,3% |
| 2024-10-23 | -€ 0,24 | -€ 0,22 | +8,3% |
| 2024-07-24 | -€ 0,26 | -€ 0,20 | +23,1% |
| 2024-04-24 | -€ 0,27 | -€ 0,26 | +3,7% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -278,69M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-47,34%
ROIC-46,15%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio9,33
Interest Coverage-7023,96
Waardering
P/E Ratio
-10,67
Forward P/EN/A
P/B Ratio6,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -359,64M |
| ROE | -47,34% | ROA | -50,25% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -278,69M |
| ROIC | -46,15% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 9,33 |
| Interest Coverage | -7023,96 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10,67 | Forward P/E | N/A |
| P/B Ratio | 6,00 | P/S Ratio | N/A |
| PEG Ratio | -0,05 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 535,23 | Fwd Earnings Yield | N/A |
| FCF Yield | -7,26% | ||
| Market Cap | 3,84B | Enterprise Value | 3,67B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -359,64M | -109,96M | -85,90M | -68,87M | -54,99M |
| EPS (Diluted) | -3,19 | -1,01 | -0,91 | -0,88 | -0,70 |
| Gross Profit | -431.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -393,34M | -150,92M | -100,83M | -70,36M | -55,68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 715,73M | 908,32M | 368,49M | 168,53M | 210,66M |
| Total Liabilities | 76,67M | 28,04M | 20,07M | 23,21M | 8,78M |
| Shareholders' Equity | 639,06M | 880,28M | 348,42M | 145,32M | 201,88M |
| Total Debt | 137.000,0 | 1,12M | 1,26M | 1,56M | 29.000,0 |
| Cash & Equivalents | 165,81M | 26,68M | 55,52M | 36,63M | 26,37M |
| Current Assets | 715,60M | 907,22M | 367,23M | 167,04M | 210,53M |
| Current Liabilities | 76,67M | 27,41M | 19,14M | 21,95M | 8,78M |